Mark W. Hahn

Mark W. Hahn

Signal active

Chief Financial Officer

Bio

Mark W. Hahn is the Chief Financial Officer of Verona Pharma.

Mr. Hahn holds a Bachelor of Business Administration degree in Accounting and Finance from the University of Wisconsin-Milwaukee and is a Certified Public Accountant in the State of Maryland.

Location

Chapel Hill, North Carolina, United States, North America

Social

Primary Organization

Verona Pharma

Verona Pharma

Founded

2005

Employees

51-100

Industry

Biotechnology, Pharmaceutical, Therapeutics

Jobs history

1

Verona Pharma

Chief Financial Officer

2020 - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Mark W. Hahn is the Chief Financial Officer at Verona Pharma, based in United States, North America. With a background in Biotechnology, Mark W. Hahn has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

Vikas Sinha

Vikas Sinha

Chief Financial Officer

Martin Edwards

Martin Edwards

No designation

David Ebsworth

David Ebsworth

No designation

Anders Ullman

Anders Ullman

Non Executive Director

David Zaccardelli

David Zaccardelli

President and Chief Executive Officer

Investment portfolio

Mark W. Hahn has made 1 investments. Their Latest investment was Post-IPO Equity - Verona Pharma on Jul 17, 2020

Number of investment

1

Number of exits

1

Personal investment

1

Annouced DateOrganization NameFunding RoundMoney Raised
Jul 17, 2020
Verona Pharma Verona Pharma
Post-IPO Equity - Verona Pharma
200.0M

Partner investment

0

There is no partner investment available on this profile

Exits

1

exit.name Verona Pharma

Verona Pharma

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory dis...

Invest in industries

Recent Activity

There is no recent news or activity for this profile.